Cropley M, Cave Z, Ellis J, Middleton RW. Effect of Kava and Valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytother Res 2002;16(1):23-7.
Gastpar M, Klimm HD. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial. Phytomedicine. 2003;10(8):631-9.
Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res. 2004;18(4):297-300.
Herberg KW. Effect of Kava-Special Extract WS 1490 combined with ethyl alcohol on safety-relevant performance parameters. (In German) Blutalkohol 1993;30(2):96-105.
Lehrl S. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord. 2004;78(2):101-10.
Corrigendum to ?Clinical efficacy of kava extract WS® 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial? (J. Affect. Disord. 2004;78(2):101-10.) Erratum. J Affect Disord. 2004 Dec;83(2-3):287.
Uebelhack R, Franke L, Schewe HJ. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry 1998; 31:187-92.
Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders?a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1?5.
Woelk H, Kapoula O, Lehrl S, et al. The treatment of patients with anxiety. A double blind study: Kava extract WS 1490 versus benzodiazepine (In German). Z Allg Med. 1993;69:271?277.
